Research Article
Autologous Cytokine-Induced Killer Cell Immunotherapy Enhances Chemotherapy Efficacy against Multidrug-Resistant Tuberculosis
Table 2
The criteria for evaluation of the symptoms or signs in patients.
| Symptoms or signs | Criteria for evaluation and score | Class 0 (score 0) | Class 1 (score 1) | Class 2 (score 2) | Class 3 (score 3) |
| Cough | No | Discontinuous coughing during the day, but did not affect work life | Between classes 1 and 3 | Frequent coughing or coughing in the day and night and affecting work and sleep | Expectoration | | -50 mL | -100 mL | | Hemoptysis | No | | Hemoptysis each time 50-100 mL | | Chest pain | No | Lightly, 2-3 times a day | Severe pain, affecting normal activity, >3 times a day | Persistence, severe pain, and affecting sleep | Dyspnea | No | Little difficulty in breathing in quiet, aggravating in exercise, but did not need oxygen | Uneasy in quiet, intermittent oxygen can be improved | Cyanosis or pale, heart based on class 2, failure or coma, oxygen could not relieve | Weak | No | Light | Medium | Severe | Fever | Normal | <38°C | 38-40°C | >40°C |
|
|